EN
Distress Tolerance in Patients with Metastatic and Non-metastatic Breast Cancer: A Single-center Experience
Abstract
Background: Psychosocial difficulties occur in patients with breast cancer for many reasons including long-term treatments, organ loss, or deformity. Accordingly, we aimed to compare differences in distress tolerance levels between metastatic and non-metastatic female patients diagnosed with breast cancer and receiving chemotherapy. We also evaluated the possible relationship between distress tolerance levels and with background and clinical characteristics of the patients.
Methods: 208 eligible female patients with breast cancer who received at least three chemotherapy sessions were included in our study. According to the presence of metastasis, the patients were divided into two groups those receiving palliative (metastatic, n=126) and adjuvant (non-metastatic, n=82) chemotherapy. Besides the study-specific data form, the Distress Tolerance Scale (DTS) was applied to patients to assess distress tolerance levels.
Results: The age of participants was statistically significant between the non-metastatic and metastatic patients(p<0.05). There was no significant statistical difference in DTS scores between non-metastatic and metastatic patients. DTS levels were significantly correlated with the presence of inpatient admission. Multiple linear regression analysis indicated that the absence of inpatient admission was significantly associated with DTS levels in patients with breast cancer(B:-13.792, p<0.01).
Conclusion: Distress tolerance is important in such a long-term illness to cope with the difficulties in the treatment. DTS may not be directly related to the stage of illness. Since inpatient admission reduces distress tolerance, it may be important in the treatment processes of these patients. Preventing possible causes of hospitalization may have positive effects on the capacity of these patients to cope with stress.
Keywords
References
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209–49.
- Mokhatri-Hesari P, Montazeri A. Health-related quality of life in breast cancer patients: Review of reviews from 2008 to 2018. Health Qual Life Outcomes 2020;18(1):1–25.
- Jiang J, Xu J, Cai L, et al. Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists. BMC Psychiatry 2021;21(1).
- NCCN Guidelines for Patients Distress During Cancer Care https://www.nccn.org/patients/guidelines/content/PDF/distress-patient.pdf. Accessed March 11, 2020
- Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004 9012 2004;90(12):2297–304.
- Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 2011;20(5):463–9.
- Linden W, Vodermaier AA, McKenzie R, et al. The Psychosocial Screen for Cancer (PSSCAN): Further validation and normative data. Health Qual Life Outcomes 2009;7(1):1–8.
- Simons JS, Gaher RM. The Distress Tolerance Scale: Development and Validation of a Self-Report Measure. Motiv Emot 2005 292 2005;29(2):83–102.
Details
Primary Language
English
Subjects
Psychiatry , Oncology and Carcinogenesis
Journal Section
Research Article
Authors
Early Pub Date
June 23, 2023
Publication Date
July 10, 2023
Submission Date
March 17, 2023
Acceptance Date
May 4, 2023
Published in Issue
Year 2023 Volume: 14 Number: 3
EndNote
Şahingöz Erdal G, Kırlıoğlu Balcıoğlu SS, Namlı MN (July 1, 2023) Distress Tolerance in Patients with Metastatic and Non-metastatic Breast Cancer: A Single-center Experience. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 14 3 409–414.